NCT01566630View on ClinicalTrials.gov

Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pre-eclampsia
Interventions
DRUG

Placebo

Placebo to RLX030 as intravenous infusion for 72 hours

DRUG

RLX030

RLX030 1 mg/mL vials

Trial Locations (5)

36604

Novartis Investigative Site, Mobile

40202

Novartis Investigative Site, Louisville

40503

Novartis Investigative Site, Lexington

41100

Novartis Investigative Site, Modena

77555-0587

Novartis Investigative Site, Galveston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY